Ying Xin
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 18
- MicroRNA in disease regulation 8
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 17
- Molecular Biology top 2%
- Genomics, phytochemicals, and oxidative stress 18
- Biological Psychiatry top 5%
- Pharmacology top 2%
-
- Effects of Radiation Exposure 13
-
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 8
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Xin JiangLingbin MengJinlong WeiQihe ZhangGe YangBin WangPinyi LiuLu Cai
- Journals
- Frontiers in Pharmacology (8 papers)Antioxidants (6 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ying Xin
225 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 700
- Otorhinolaryngology 187
- Molecular Biology 2.9k
- Biological Psychiatry 91
- Pharmacology 231
Countries citing papers authored by Ying Xin
This map shows the geographic impact of Ying Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xin more than expected).
Fields of papers citing papers by Ying Xin
This network shows the impact of papers produced by Ying Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xin. The network helps show where Ying Xin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Xin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 34 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 48 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 13 | |
| 13 | Applying cross-entropy difference for selecting parallel training data from publicly available sources for conversational machine translation. | 2015 | 4 |
| 14 | Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults | 2012 | 1 |
| 15 | 2012 | 1 | |
| 16 | Effects of ginsenoside Rg3 on the invasion and metastasis of mouse melanoma cell line B16 as well as the expression of MMP-9 | 2011 | 1 |
| 17 | Contribution of diabetes family history to the morbidity rate of diabetes and other risk factors. | 2010 | 1 |
| 18 | Contribution of overweight and obesity to the prevalence rate of diabetes and its other risk factors | 2010 | 1 |
| 19 | 2008 | 80 | |
| 20 | 2007 | 74 |
About Ying Xin
Ying Xin is a scholar working on Otorhinolaryngology, Cancer Research and Molecular Biology, having authored 235 papers that have together received 5.7k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (18 papers), Cancer-related molecular mechanisms research (18 papers), Head and Neck Cancer Studies (17 papers), Effects of Radiation Exposure (13 papers), Lung Cancer Research Studies (13 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (700 citations), Otorhinolaryngology (187 citations) and Molecular Biology (2.9k citations). Ying Xin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xin Jiang, Lingbin Meng, Jinlong Wei, Qihe Zhang, Ge Yang, Bin Wang, Pinyi Liu, Lu Cai, Huanhuan Wang and Yi Tan. Their work appears in journals such as Frontiers in Pharmacology, Antioxidants, Journal of Clinical Oncology, Biomedicine & Pharmacotherapy and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.